The report goes on to say that, “TCS has been recognized for the strategic direction that it brings to IT transformation initiatives, its flexibility and agility despite its scale, and its end-to-end project delivery capabilities.”
“TCS leverages its domain knowledge, intellectual property and contextual solutions designed using the combinatorial power of cutting-edge technologies to help clients transform and scale their R&D initiatives and achieve their purpose-driven goals," said Vikas Jain, Global Co-Head, Life Sciences, TCS. “This leadership position is a reflection of our strategies, capabilities, investments in intellectual property, and the resultant market success.”
TCS partners with leading life sciences companies to drive innovation and reimagine their R&D processes by leveraging next-generation platforms and emerging technologies. TCS offers a full set of services spanning advisory, digital transformation, and cognitive business operations in areas such as digitization of clinical trials, paperless and integrated lab environment, blockchain-enabled clinical supply chain, AI-enabled case processing, and discovery collaboration. The solutions use a combination of artificial intelligence, cognitive computing capabilities, robotic process automation, Internet of Things and cloud to fully digitize the life sciences value chain.
At around 12.13 pm, TCS was trading at Rs3892.05 per piece up 0.6% on Sensex.